Viz™ LVO
Initial Real-World Experience With Viz LVO in Transferred Large...
Background Randomized controlled trials have demonstrated the importance of time to endovascular therapy (EVT) on clinical outcomes in large vessel...
Mar 11, 2021
VALIDATE: Validation of Artificial Intelligence to Limit Delays in Acute Stroke Treatment and Endovascular Therapy
A total of 14,116 patients (8,557 AI and 5,559 non-AI) were included. The median door to NIR notification time for AI was 50 minutes (40, 82) and non-AI was 89.5 minutes (59.3, 122), p <0.001. Median DTN times for thrombolytics was also lower with AI, 40 minutes (30, 52) vs 44 minutes (32, 57.5) for non-AI, p=0.018.
Viz™ LVO
Background Randomized controlled trials have demonstrated the importance of time to endovascular therapy (EVT) on clinical outcomes in large vessel...
Mar 11, 2021
Viz™ ANEURYSM
Objective Machine learning algorithms have shown groundbreaking results in neuroimaging. The authors herein evaluated the performance of a newly developed...
Mar 03, 2023
Viz™ LVO
Background Comprehensive Stroke Centers (CSCs) strive to narrow rt-PA and “Door To Groin” (DTG) neurointerventional (NIR) times. Process improvement workflows...
Feb 03, 2022
Schedule a meeting
Experience the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.